Teladoc Health, Inc.
—- Market cap
- $1.14B
- Debt
- —
- Cash
- −$781.08M
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt cap
Decision snapshot: TDOC stock price at discount vs ITRI $6.26 current versus $24.87 implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at ITRI's multiple
Implied fair value · at TDOC's multiple
Snapshot Sep 8, 2026, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
13 period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
TELADOC HEALTH, INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Itron, Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Hims & Hers Health, Inc.
TDOC vs HIMS
GoodRx Holdings, Inc.
TDOC vs GDRX
Cigna Group
TDOC vs CI
VEEVA SYSTEMS INC
TDOC vs VEEV
EMERSON ELECTRIC CO
TDOC vs EMR
Eaton Corp plc
TDOC vs ETN
BADGER METER INC
TDOC vs BMI
CISCO SYSTEMS, INC.
TDOC vs CSCO
Leidos Holdings, Inc.
TDOC vs LDOS
VERISIGN INC/CA
TDOC vs VRSN
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.